You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cytoxan

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial in Houston (Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN

Active, not recruiting
  • Neuroblastoma
  • Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN neuroblastoma cells
  • Cytoxan
  • Houston, Texas
    Texas Children's Hospital
Mar 25, 2022

Crohn Disease Trial in Los Angeles (drug, procedure, biological)

Recruiting
  • Crohn Disease
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 23, 2022

Hematologic Malignancies Trial in Baltimore (drug, radiation, procedure)

Recruiting
  • Hematologic Malignancies
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022

Metastatic Cancer Trial in Rochester (Keytruda Injectable Product, Yervoy Injectable Product, Cytoxan)

Recruiting
  • Metastatic Cancer
  • Keytruda Injectable Product
  • +4 more
  • Rochester, Michigan
    Ascension Providence Rochester Hospital
Jun 15, 2022

Congenital Pediatric Disorders Trial in Houston (Busulfan, Cytoxan, Fludarabine)

Active, not recruiting
  • Congenital Pediatric Disorders
  • Houston, Texas
    Texas Children's Hospital
Feb 4, 2022

Metastatic Prostatic Adenocarcinoma Trial in Lancaster, Rochester (Opdivo Injectable Product, Yervoy Injectable Product,

Completed
  • Metastatic Prostatic Adenocarcinoma
  • Opdivo Injectable Product
  • +3 more
  • Lancaster, California
  • +1 more
Jun 15, 2022

Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

Recruiting
  • Liver Cell Carcinoma
  • +7 more
  • CATCH T cells
  • +2 more
  • Houston, Texas
    Houston Methodist Hospital
Dec 19, 2022

Neuroblastoma Trial in Houston (iC9-GD2 T Cells - frozen, iC9-GD2 T Cells - fresh, Cytoxan)

Active, not recruiting
  • Neuroblastoma
  • iC9-GD2 T Cells - frozen
  • +5 more
  • Houston, Texas
  • +1 more
Jan 4, 2023

Hepatocellular Carcinoma Trial in Houston (GLYCAR T cells, Cytoxan, Fludarabine)

Active, not recruiting
  • Hepatocellular Carcinoma
  • GLYCAR T cells
  • +2 more
  • Houston, Texas
    Houston Methodist Hospital
Feb 13, 2022

Leukemia, Myeloid, Acute Trial in Chongqing (anti-CD33 CAR NK cells, Fludarabine, Cytoxan)

Recruiting
  • Leukemia, Myeloid, Acute
  • anti-CD33 CAR NK cells
  • +2 more
  • Chongqing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
Dec 22, 2021

Multiple Myeloma, Refractory Trial in Chongqing (Anti-BCMA CAR-NK Cells, Fludarabine, Cytoxan)

Recruiting
  • Multiple Myeloma, Refractory
  • Anti-BCMA CAR-NK Cells
  • +2 more
  • Chongqing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
Nov 21, 2021

Human Papillomavirus-Related Carcinoma, Human Papillomavirus Positive Oropharyngeal Carcinoma, Human Papillomavirus Positive

Active, not recruiting
  • Human Papillomavirus-Related Carcinoma
  • +5 more
  • HPV Specific T Cells
  • +3 more
  • Houston, Texas
    Houston Methodist Hospital
Jan 10, 2022

Liver Cancer, Rhabdomyosarcoma, Malignant Rhabdoid Tumor Trial in Houston (CARE T cells, Cytoxan, Fludara)

Not yet recruiting
  • Liver Cancer
  • +5 more
  • CARE T cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Dec 1, 2021

Leukemia, Myeloid, Acute Trial in Chongqing (Fludarabine, Cytoxan, Dual CD33-CLL1 CAR-T cells)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Chongqing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
Aug 20, 2021

Hematological Malignancy, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission Trial in New York (Cord blood

Completed
  • Hematological Malignancy
  • +5 more
  • Cord blood stem cells
  • +5 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
May 20, 2021

T-cell Leukemia, T-cell Lymphoma Trial in ChongQing (CD7 UCAR-T cells, Fludarabine, Cytoxan)

Recruiting
  • T-cell Leukemia
  • T-cell Lymphoma
  • CD7 UCAR-T cells
  • +3 more
  • ChongQing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
Jun 21, 2021

Hepatocellular Carcinoma, Hepatoblastoma Trial (TEGAR T cells, Cytoxan, Fludarabine)

Withdrawn
  • Hepatocellular Carcinoma
  • Hepatoblastoma
  • TEGAR T cells
  • +2 more
  • (no location specified)
May 19, 2020

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Trial in ChongQing (anti-CD19 UCAR-T cells, Fludarabine, Cytoxan)

Unknown status
  • B-cell Acute Lymphoblastic Leukemia
  • B-cell Lymphoma
  • anti-CD19 UCAR-T cells
  • +3 more
  • ChongQing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
Feb 7, 2020

Bone Cancer, Ewing's Sarcoma Trial in Stanford (Irinotecan, Vincristine, Temozolomide)

Terminated
Has Results
  • Bone Cancer
  • Ewing's Sarcoma
  • Stanford, California
    Stanford University School of Medicine
Oct 20, 2017

Breast Cancer Trial in Atlanta (Exemestane, Docetaxel, Cytoxan)

Completed
Has Results
  • Breast Cancer
  • Atlanta, Georgia
  • +2 more
Feb 24, 2017

Lymphoma Trial in Houston (Cytoxan, Nipent, Rituxan)

Completed
Has Results
  • Lymphoma
  • Cytoxan
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 13, 2016

Breast Cancer Trial in United States (Taxotere, Cytoxan, Herceptin)

Completed
Has Results
  • Breast Cancer
  • Birmingham, Alabama
  • +68 more
Sep 15, 2016

Aplastic Anemia Trial in Houston (drug, radiation, procedure)

Terminated
Has Results
  • Aplastic Anemia
  • Cytoxan
  • +5 more
  • Houston, Texas
  • +1 more
Mar 24, 2016

Multiple Myeloma Trial in Little Rock (Thalidomide, Ara-C, BCNU)

Completed
Has Results
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences/MIRT
Oct 21, 2015

Leukemia, B-cell Leukemia, Chronic Leukemia Trial in Stanford (Alemtuzumab, Fludarabine, Cytoxan)

Completed
Has Results
  • Leukemia
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
Sep 25, 2014